Shearman & Sterling LLP multinational law firm headquartered in New York City, United States.

イベント Mar 20, 2019

Curing Corruption in China’s Healthcare Industry Risks and Opportunities

  • Hong Kong

Partner Brian Burke (New York/Shanghai – Litigation) presented on the topic of “Curing Corruption in China’s Healthcare Industry – Risks and Opportunities” at a briefing hosted by The British Chamber of Commerce in Hong Kong. The briefing addressed the following topics:

  • Key FCPA/UKBA enforcement risks in China’s healthcare industry
  • Case Studies: Lessons from notable enforcement cases (including GSK, Novartis, Astra Zeneca, SciClone and BMS)
  • Observations on the latest kinds of employee and third-party misconduct
  • How to promote compliance and mitigate enforcement risks